- Home
- ADVM vs IDR Comparison
ADVM vs IDR Comparison
Compare ADVM & IDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVM
- IDR
- Stock Information
- Founded
- ADVM 2006
- IDR 1996
- Country
- ADVM United States
- IDR United States
- Employees
- ADVM N/A
- IDR N/A
- Industry
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- IDR Precious Metals
- Sector
- ADVM Health Care
- IDR Basic Materials
- Exchange
- ADVM Nasdaq
- IDR Nasdaq
- Market Cap
- ADVM 119.6M
- IDR 142.7M
- IPO Year
- ADVM 2014
- IDR N/A
- Fundamental
- Price
- ADVM $4.25
- IDR $10.28
- Analyst Decision
- ADVM Strong Buy
- IDR Strong Buy
- Analyst Count
- ADVM 6
- IDR 1
- Target Price
- ADVM $27.83
- IDR $14.00
- AVG Volume (30 Days)
- ADVM 217.5K
- IDR 137.4K
- Earning Date
- ADVM 11-04-2024
- IDR 11-04-2024
- Dividend Yield
- ADVM N/A
- IDR N/A
- EPS Growth
- ADVM N/A
- IDR 344.27
- EPS
- ADVM N/A
- IDR 0.52
- Revenue
- ADVM $1,000,000.00
- IDR $21,955,008.00
- Revenue This Year
- ADVM N/A
- IDR $86.37
- Revenue Next Year
- ADVM $1,342.84
- IDR $11.11
- P/E Ratio
- ADVM N/A
- IDR $20.08
- Revenue Growth
- ADVM N/A
- IDR 64.93
- 52 Week Low
- ADVM $4.01
- IDR $5.66
- 52 Week High
- ADVM $29.70
- IDR $18.35
- Technical
- Relative Strength Index (RSI)
- ADVM 29.33
- IDR 41.05
- Support Level
- ADVM $4.42
- IDR $10.06
- Resistance Level
- ADVM $5.11
- IDR $10.81
- Average True Range (ATR)
- ADVM 0.30
- IDR 0.43
- MACD
- ADVM 0.01
- IDR 0.10
- Stochastic Oscillator
- ADVM 21.05
- IDR 51.78
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.
About IDR Idaho Strategic Resources Inc.
Idaho Strategic Resources Inc is a vertically integrated, operating junior mining company. It produces gold at the Golden Chest Mine. In addition to gold and gold production, the company maintains a strategic and domestic presence in the Critical Minerals sector and is focused on advancing its officially recognized Lemhi Pass, Diamond Creek, and Roberts Rare Earth Element projects in central Idaho.